Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-31

Clinical Trial Update: Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase III trial comparing Atamestane plus toremifene versus letrozole for advanced breast cancer has completed enrollment. The snippet does not provide efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atamestane (atamestane)
  • Letrozole (letrozole)
  • Toremifene (toremifene)

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Breast Neoplasms, Neoplasms, Hormone-dependent | Phase 3 | Status: COMPLETED